Skip to Content

145 145 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint 145 145 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 145 145

Rivastigmine Tartrate

Imprint:
145 145
Strength:
1.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharmaceutical Industries Inc.
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
gelatin
titanium dioxide
D&C Red No. 28
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0550 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide